RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $851,000 | -27.0% | 321,100 | 0.0% | 0.02% | -11.5% |
| Q3 2021 | $1,166,000 | -16.4% | 321,100 | 0.0% | 0.03% | -7.1% |
| Q2 2021 | $1,394,000 | +27.0% | 321,100 | 0.0% | 0.03% | +47.4% |
| Q1 2021 | $1,098,000 | -2.3% | 321,100 | 0.0% | 0.02% | -20.8% |
| Q4 2020 | $1,124,000 | +45.8% | 321,100 | 0.0% | 0.02% | +26.3% |
| Q3 2020 | $771,000 | +24.6% | 321,100 | -5.0% | 0.02% | +11.8% |
| Q2 2020 | $619,000 | +13.4% | 338,000 | -3.4% | 0.02% | -26.1% |
| Q1 2020 | $546,000 | – | 350,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |